These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16410022)

  • 1. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility.
    Koromila G; Michanetzis GP; Missirlis YF; Antimisiaris SG
    Biomaterials; 2006 Apr; 27(12):2525-33. PubMed ID: 16410022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.
    Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes.
    Kastellorizios M; Michanetzis GP; Pistillo BR; Mourtas S; Klepetsanis P; Favia P; Sardella E; d'Agostino R; Missirlis YF; Antimisiaris SG
    Int J Pharm; 2012 Aug; 432(1-2):91-8. PubMed ID: 22569232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents.
    Kallinteri P; Antimisiaris SG; Karnabatidis D; Kalogeropoulou C; Tsota I; Siablis D
    Biomaterials; 2002 Dec; 23(24):4819-26. PubMed ID: 12361621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin-conjugated liposomes with improved stability and hemocompatibility.
    Köse GT; Arica MY; Hasirci V
    Drug Deliv; 1998; 5(4):257-64. PubMed ID: 19569993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes.
    Song YK; Kim CK
    Biomaterials; 2006 Jan; 27(2):271-80. PubMed ID: 16039711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome coated stents: a method to deliver drugs to the site of action and improve stent blood-compatibility.
    Antimisiaris SG; Koromila G; Michanetzis G; Missirlis YF
    J Liposome Res; 2006; 16(3):303-9. PubMed ID: 16952883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and antithrombogenicity of oxidated low molecular weight heparin-antithrombin complex coated-polyvinyl chloride tubing].
    Luo P; Liu W; Yang C; Zhou H; Cao R; Yang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):90-4. PubMed ID: 21485191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
    Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-coated metal stents: an in vitro evaluation of controlled-release modality in the ureter.
    Antimisiaris SG; Siablis D; Liatsikos E; Kalogeropoulou C; Tsota I; Tsotas V; Karnabatidis D; Fatouros DG; Barbalias GA
    J Endourol; 2000 Nov; 14(9):743-7. PubMed ID: 11110569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of a novel oral delivery system for low molecular weight heparin.
    Lavanya N; Muzib YI; Aukunuru J; Balekari U
    Int J Pharm Investig; 2016; 6(3):148-57. PubMed ID: 27606258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High encapsulation efficiencies in sized liposomes produced by extrusion of dehydration-rehydration vesicles.
    Aliño SF; Garcia-Sanz M; Irruarrizaga A; Alfaro J; Hernandez J
    J Microencapsul; 1990; 7(4):497-503. PubMed ID: 2266475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
    Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
    Chung TW; Yang MC; Tsai WJ
    Int J Pharm; 2006 Mar; 311(1-2):122-9. PubMed ID: 16446064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.